neutrophil-to-lymphocyte ratio

You have access
Potential of Inflammatory and Nutritional Markers and Clinicopathological Factors for Prognostic Prediction in Osteosarcoma
KAZUHIKO HASHIMOTO, SHUNIJI NISHIMURA and KOJI GOTO

Anticancer Research May 2026, 46 (5) 2713-2723; DOI: https://doi.org/10.21873/anticanres.18151
You have access
Prognostic Value of the C-Reactive Protein-albumin-lymphocyte Index For Patients With Recurrent οr Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab
FUMIHIKO SATO, TAKEHARU ONO, AKIRA HIRAKI, TSUNEHIRO OKA, TOSHIYUKI MITSUHASHI, MASAYASU NAITO, MIOKO FUKAHORI, SHINTARO SUEYOSHI, ITARU MIZOBE, MASAHIRO SEKI, KIMINOBU SATO, TOSHIHIKO KAWAGUCHI, HISAICHIRO TANAKA, TAKASHI KURITA, SHUN-ICHI CHITOSE and HIROHITO UMENO

Anticancer Research September 2025, 45 (9) 3993-4004; DOI: https://doi.org/10.21873/anticanres.17757
Open Access
Novel UF-5000-based Detection, Integrating Inflammatory Parameters, for Urothelial Carcinoma of the Urinary Bladder
KAZUHIRO OKADA, YOSHIKI NAITO, SAORI IRIE, CHIKA NAKAMOTO, KENJI KUBOYAMA, TOSHIKI TARUMIZU, MISAKI IKEDA, YUKO TAKUMA, RYO MAKINO, AKIHIKO KAWAHARA and HIROYUKI KAWANO

Anticancer Research August 2025, 45 (8) 3531-3541; DOI: https://doi.org/10.21873/anticanres.17714
Open Access
Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study
ALEXIA GIRO, JUDITH PASSILDAS-JAHANMOHAN, MYRIAM KOSSAI, YANNICK BIDET, IOANA MOLNAR, MAUREEN BERNADACH, FREDERIQUE PENAULT-LLORCA, CATHERINE ABRIAL, XAVIER DURANDO and NINA RADOSEVIC-ROBIN

Anticancer Research November 2024, 44 (11) 4983-4994; DOI: https://doi.org/10.21873/anticanres.17323
You have access
Serum Inflammatory Dynamics as Novel Biomarkers for Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer With Bone Metastases
YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SATOSHI KATO, SHINJI MIWA, MIHO OKUDA, ISAO MATSUMOTO, SEIJI YANO and SATORU DEMURA

Anticancer Research October 2024, 44 (10) 4493-4503; DOI: https://doi.org/10.21873/anticanres.17278
Open Access
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment
YUYA HIRASAWA, YUTARO KUBOTA, EMIKO MURA, RISAKO SUZUKI, TOSHIAKI TSURUI, NANA IRIGUCHI, TOMOYUKI ISHIGURO, RYOTARO OHKUMA, MASAHIRO SHIMOKAWA, HIROTSUGU ARIIZUMI, ATSUSHI HORIIKE, SATOSHI WADA, TOMOTAKE ARIYOSHI, SATORU GOTO, KOJI OTSUKA, MASAHIKO MURAKAMI, YUJI KIUCHI, KIYOSHI YOSHIMURA, ROBERT M. HOFFMAN and TAKUYA TSUNODA

Anticancer Research August 2024, 44 (8) 3397-3407; DOI: https://doi.org/10.21873/anticanres.17160
You have access
Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for Advanced Urothelial Carcinoma: The UROKYU Study
NOBUKI FURUBAYASHI, AKINORI MINATO, TOSHIHISA TOMODA, YOSHIFUMI HORI, KEIJIRO KIYOSHIMA, TAKAHITO NEGISHI, YUSUKE HARAGUCHI, TOSHIKI KOGA, KENICHI HARADA, KENTARO KUROIWA, NAOHIRO FUJIMOTO, MOTONOBU NAKAMURA and Uro-Oncology Group in Kyushu (UROKYU)

Anticancer Research April 2024, 44 (4) 1675-1681; DOI: https://doi.org/10.21873/anticanres.16966
Open Access
Durvalumab Outcomes in Stage III Non-small Cell Lung Cancer: A Single-institution Study
JONATHAN Q. TRINH, YING XIONG, LYNETTE M. SMITH, OMAR ABUGHANIMEH, ALISSA S. MARR and APAR K. GANTI

Anticancer Research February 2024, 44 (2) 605-612; DOI: https://doi.org/10.21873/anticanres.16849
You have access
Efficacy of Adding Locoregional Therapy in Non-Complete Remission Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Preliminary Study
TORU ISHIKAWA, SHUN YAMAZAKI, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA

Anticancer Research January 2024, 44 (1) 361-368; DOI: https://doi.org/10.21873/anticanres.16819
You have access
New Scale Predicting Distant Recurrence in Locally Advanced Lower Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
RYOSUKE NAKAGAWA, TSUTOMU KUMAMOTO, FUMI MAEDA, KIMITAKA TANI, HIROKA KONDO, KURODO KOSHINO, YUKA KANEKO, YOSHIKO BAMBA, SHIMPEI OGAWA, YUJI INOUE, MICHIO ITABASHI and SHIGEKI YAMAGUCHI

Anticancer Research May 2023, 43 (5) 2179-2184; DOI: https://doi.org/10.21873/anticanres.16380

Main menu

User menu

Search

neutrophil-to-lymphocyte ratio

Pages